Aquila Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $914K | Hold |
13,000
| – | – | 1.02% | 36 |
|
|
2024
Q2 | $1.07M | Hold |
13,000
| – | – | 1% | 45 |
|
|
2024
Q1 | $1.14M | Hold |
13,000
| – | – | 0.97% | 47 |
|
|
2023
Q4 | $1.25M | Buy |
13,000
+5,000
| +63% | +$482K | 1.08% | 46 |
|
|
2023
Q3 | $708K | Hold |
8,000
| – | – | 0.65% | 64 |
|
|
2023
Q2 | $693K | Hold |
8,000
| – | – | 0.57% | 71 |
|
|
2023
Q1 | $778K | Sell |
8,000
-3,000
| -27% | -$292K | 0.64% | 64 |
|
|
2022
Q4 | $1.14M | Hold |
11,000
| – | – | 0.88% | 54 |
|
|
2022
Q3 | $932K | Hold |
11,000
| – | – | 0.7% | 64 |
|
|
2022
Q2 | $912K | Buy |
11,000
+3,000
| +38% | +$249K | 0.65% | 66 |
|
|
2022
Q1 | $617K | Hold |
8,000
| – | – | 0.35% | 79 |
|
|
2021
Q4 | $707K | Buy |
+8,000
| New | +$707K | 0.34% | 84 |
|